Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
08:50 - 09:00 10 mins
Stream 1: Compliance - Data Privacy and Anti-Bribery
Opening remarks from the Chairperson
  • Kristof Van Quathem - Special Counsel, Covington & Burling LLP, Belgium
08:50 - 09:00 10 mins
Stream 2: Licensing and Collaboration Agreements
Opening remarks from the Chairperson
  • Daniel Pavin - Partner, Covington & Burling LLP, UK
09:00 - 09:40 40 mins
Info
Stream 1: Compliance - Data Privacy and Anti-Bribery
Practical steps towards implementation of the EU General Data Protection Regulation
  • Kristof Van Quathem - Special Counsel, Covington & Burling LLP, Belgium
  • Appointing a Data Protection Officer
  • Dealing with Safe Harbor rules and the GDPR
  • Potential for divergent national data protection laws between Member States
09:00 - 09:40 40 mins
Info
Stream 2: Licensing and Collaboration Agreements
The changing face of the pharmaceutical industry: impact on licensing and collaborations
  • Carolyn Heath - Legal & Compliance Advisor, Heath Consulting and Enterprises Ltd., UK
  • Alex Denoon - Partner, Marriott Harrison, UK
  • How will Brexit impact licensing and transactions now and in the future?
  • Licensing of trademarks and registered design portfolios in light of Brexit
  • Future outlook: other significant changes that will impact licensing and collaborations
09:40 - 10:20 40 mins
Info
Stream 1: Compliance - Data Privacy and Anti-Bribery
Multi-party collaborations in pharma
  • Michael Gavey - Partner, Simmons & Simmons, UK
  • Olivier Mignolet - Partner, Simmons & Simmons, UK
  • Examining the structure of deals between tertiary institutions, government and industry
  • Challenges presented with a multi-party collaboration format
  • Financial and sub-licensing implications
  • Understanding the interests and goals of academia
09:40 - 10:20 40 mins
Info
Stream 2: Licensing and Collaboration Agreements
Multi-party collaborations in pharma
  • Michael Gavey - Partner, Simmons & Simmons, UK
  • Olivier Mignolet - Partner, Simmons & Simmons, UK
  • Examining the structure of deals between tertiary institutions, government and industry
  • Challenges presented with a multi-party collaboration format
  • Financial and sub-licensing implications
  • Understanding the interests and goals of academia
10:20 - 10:50 30 mins
Morning coffee and networking break
10:50 - 11:30 40 mins
Info
Stream 1: Compliance - Data Privacy and Anti-Bribery
Carrying out an internal data protection audit in a life sciences company
  • Paul Ranson - Consultant, Morgan, Lewis & Bockius LLP, UK
  • Pulina Whitaker - Partner, Morgan, Lewis & Bockius LLP, UK
  • Taking into account obligations of the GDPR and ensuring compliance
  • How to check what data flows there are and where they are going to
  • Determining what is anonymous
  • Producing an audit report and implementing follow-up actions
10:50 - 11:30 40 mins
Info
Stream 2: Licensing and Collaboration Agreements
Collaborations for the development of combination therapies
  • Patrick Duxbury - Partner, Intellectual Property, Gowling WLG, UK
  • Examining the benefits of shared resources and expertise
  • Financial implications
  • Overcoming cultural challenges
  • Future outlook for combination therapy collaborations
11:30 - 12:10 40 mins
Info
Stream 2: Licensing and Collaboration Agreements
Reviewing commercial IP issues in collaboration and licensing agreements
  • Frank Landolt - V.P. Intellectual Property and Legal, Ablynx N.V., Belgium
  • Sally Shorthose - Partner, Bird & Bird, UK
  • Understanding the ownership of IP
  • IP rights of each party
  • Joint ownership issues
  • IP protection and enforcement
12:10 - 13:40 90 mins
Networking lunch
13:40 - 14:20 40 mins
Info
Stream 1: Compliance - Data Privacy and Anti-Bribery
DUAL DIALOGUE: Sunshine and transparency laws across Europe with regards to payments to healthcare professionals
  • Martin Dræbye Gantzhorn - Partner, Co-Head Life Sciences, Bech-Bruun, Denmark
  • Marc Christian Bauer - Vice President – Head of Legal and Compliance International, Tesaro, Switzerland
  • Examining EFPIA codes, how they work and any problems seen
  • Reviewing different requirements and practices in countries across Europe
  • How to interpret, report and enforce
  • Comparison of the U.S. Sunshine Act and the EU
13:40 - 14:20 40 mins
Info
Stream 2: Licensing and Collaboration Agreements
Planning, negotiating and drafting termination provisions in generic licensing agreements
  • Nikhil Patel - Associate General Counsel – Global Commercial, DSM Sinochem Pharmaceuticals Netherlands B.V., The Netherlands
  • Termination clauses – termination for convenience & cause
  • Negotiating termination by mutual consent
  • Consequences of termination: Licensor and licensee perspective
14:20 - 15:00 40 mins
Info
Stream 1: Compliance - Data Privacy and Anti-Bribery
Data privacy in the context of mobile apps and eHealth
  • Janice Carling - Senior Legal Counsel, Data Privacy, Teva Pharmaceuticals, International
  • Nicola Orlandi - Global Head Data Privacy, Novartis International AG, Switzerland
  • Status of the ePrivacy Regulation and implications for industry
  • Status of the EU Commission’s Code of Conduct on privacy for mobile apps
  • What data is processed and for what purposes?
  • Data processing: How should patients/consumers be informed?
  • Data privacy considerations for new technologies in healthcare including AI and VR
14:20 - 15:00 40 mins
Info
Stream 2: Licensing and Collaboration Agreements
DUAL DIALOGUE: Assessing the financial aspects of licensing and collaboration agreements
  • Claire Solk - Senior Counsel, Corporate UK, AstraZeneca, UK
  • Economic considerations
  • Examining upfront payments
  • At what stages are developmental and commercial milestones paid?
  • Overcoming key pitfalls
15:00 - 15:30 30 mins
Afternoon tea and networking break
15:30 - 16:10 40 mins
Info
Stream 1: Compliance - Data Privacy and Anti-Bribery
Implementing an effective anti-bribery compliance program
  • David Corker - Partner, Corker Binning, UK
  • Best practice for implementing a successful anti-bribery compliance program
  • Monitoring procedures and reporting violations
  • Dealing with audits
  • Reviewing anti-bribery laws in different Member States
15:30 - 16:10 40 mins
Info
Stream 2: Licensing and Collaboration Agreements
DUAL DIALOGUE: The importance of due diligence
  • Lucinda Osborne - Partner, Covington & Burling LLP, UK
  • Laetitia Szaller - Associate General Counsel, Business Development & Technical Operations, UCB, Belgium
  • Due diligence as the start of a relationship between parties: how to build trust in you as a partner
  • Impact on the structure and terms of the proposed transaction
  • Ensuring confidentiality and maintaining privilege
16:10 - 16:50 40 mins
Info
Stream 1: Compliance - Data Privacy and Anti-Bribery
Extended Q&A Session

A chance for any remaining questions from the day

Led by the Chairperson

16:10 - 16:50 40 mins
Info
Stream 2: Licensing and Collaboration Agreements
DUAL DIALOGUE: Co-promotion and co-marketing agreements in the pharma industry
  • Emmanuelle Trombe - Partner, McDermott Will & Emery, France
  • Matthieu Guérineau - Head of Contracts and Legal Coordination Department, Servier, France
  • What are the differences between co-marketing and co-promotion agreements?
  • Financial implications
  • Competition law considerations for these agreements
16:50 - 16:55 5 mins
Chair's Closing Remarks and End of Conference Day
Showing of Streams
10:20 - 10:50

Morning coffee and networking break

More
Showing of Streams
12:10 - 13:40

Networking lunch

More
Showing of Streams
15:00 - 15:30

Afternoon tea and networking break

More
Showing of Streams
16:50 - 16:55
Chair's Closing Remarks and End of Conference Day

Chair's Closing Remarks and End of Conference Day

More